Morgan Stanley 24th Annual Global Healthcare Conference
Logotype for Lifestance Health Group Inc

Lifestance Health Group (LFST) Morgan Stanley 24th Annual Global Healthcare Conference summary

Event summary combining transcript, slides, and related documents.

Logotype for Lifestance Health Group Inc

Morgan Stanley 24th Annual Global Healthcare Conference summary

15 Sep, 2026

Market overview and positioning

  • Outpatient mental health remains highly fragmented, with many small or solo practices and limited insurance acceptance, leading to access challenges and inefficiencies.

  • Demand for mental health services is rising as social stigma decreases, increasing pressure on the system.

  • The organization is the largest national outpatient mental health provider, with 8,500 clinicians and 600 centers across 34 states, recently expanding into Iowa.

Addressing supply-demand imbalance and productivity

  • Despite clinician shortages, thousands of appointment slots go unused weekly due to inefficiencies.

  • Clinician base grows near double digits annually, improving access for payers.

  • In-person care is prioritized alongside virtual, meeting payer needs and differentiating from virtual-only entrants.

  • Productivity initiatives include increasing clinician hours, optimizing scheduling, and leveraging AI for patient intake, resulting in a 7% year-over-year productivity improvement.

  • Utilization of clinician capacity is about 70%, with ongoing efforts to increase this through data-driven best practices and nationwide rollout of successful retention strategies.

Revenue, reimbursement, and growth outlook

  • Revenue per visit reached the high end of low to mid-single-digit targets, driven by Medicare-linked contracts and payer negotiations.

  • Medicare reimbursement for mental health saw a high single-digit increase for 2026, with expectations for continued low to mid-single-digit growth in coming years.

  • Revenue growth is guided at 20% for the year, with mid-teen visit growth and a four-year CAGR of 19%.

  • Growth is supported by improved reimbursement, double-digit clinician additions, and significant market expansion opportunities.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more